US Leadership Summit


Like this article?

Sign up to our free newsletter

OnSite Waste Technologies secures USD3.5m in Series A funding

OnSite Waste Technologies, a specialist in the immediate sterilisation of medical waste, has closed an oversubscribed USD3.5 million Series A funding round. OnSite has now raised a total of USD8.5 million in capital, which has helped contribute to a 500 per cent, quarter-over-quarter growth rate.The latest round of funding was led by Mark IV Capital – a Newport Beach, California-based asset management firm focused on venture capital among other sectors. The capital raised from this funding round will be used to scale, build inventory and distribute the company’s TE-5000 immediate sterilisation desktop unit. Previous funding rounds focused on early stage development, R&D and go-to-market strategies.

“We’ve now proven that small quantity generators of medical waste have a significant interest in the immediate sterilisation, made possible by our OnSite TE-50001,” says Brad Barnes, CEO at OnSite Waste Technologies. “Now that we have clear market fit, we’re scaling the business, and focusing on getting the TE-5000 into as many long-term care facilities, family practices, dermatologists offices, urgent care clinics, and other small waste producer settings as possible.”

Like this article? Sign up to our free newsletter




Blackstone Private Equity

Talk to Us

What would you like to talk with us about? *